The Compound has actually been researched within the patent literature for its anxiolytic properties and decreased sedative, hypnotic, and ataxic facet-outcomes, but it does not appear to be accredited for health-related use. Łukasik-Głebocka et al Flubromazolam was initial recognized in the sample of ten white rectangle formed tablets labelled “XANAX”, https://chemicalglobe.com/